Search for:
Author

Ashish Chugh

Browsing
Ashish is a Local Principal in Singapore's Dispute Resolution Practice Group. He is qualified to practice law in England & Wales, India, New York and Singapore. In July 2018, Ashish received the “Under-40 Rising Star” award at the annual India law awards ceremony in New Delhi. Recent clients commentary in The Legal 500 Asia Pacific states that "Ashish is 'very familiar with India law matters', 'offers commercially sensible advice and is a delight to work with', and 'grasps complex points quickly and is very persuasive' (2019) and describes Ashish as "truly impressive", "very incisive and a go-to lawyer in Singapore", who offers "advice that is sensible and commercially viable" (2018).

ESG disputes pose one of the top risks to organizations in the coming year, particularly the increasing concern of governance disputes. Join Baker McKenzie’s global team on 31 January 2023 as they discuss key risks to your organization as well as how to manage these and adapt to changing demands.

Looking to the year ahead, Baker McKenzie commissioned a survey of 600 senior lawyers across the globe and uncovered that corporations expect more disputes this year, driven by economic uncertainty, global trade shifts and altered business models. Disputes around cybersecurity/data and ESG rank as emerging risk areas, while tax and employment disputes remain a constant consideration for organizations. To help stay abreast of emerging challenges and prepare to navigate the changing disputes landscape, join our experts across the globe in a series of webinars as they unpack findings from our latest report, The Year Ahead: Global Disputes Forecast 2023, and uncover a practical, actionable way forward.

Our annual report, The Year Ahead: Global Disputes Forecast 2022, addresses key trends in the disputes landscape around the globe, and we invite you to join us for a webinar series focused on key issues identified in the report including litigation preparedness, ESG, digital transformation and healthcare and life sciences.